We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HMN:NYSEHorace Mann Educators Corporation Analysis

Data as of 2026-05-21 - not real-time

$47.65

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Horace Mann (HMN) is trading at $47.65, comfortably above its 20‑day ($45.53), 50‑day ($44.34) and 200‑day ($44.67) simple moving averages, indicating a bullish price trend. The RSI sits at 69.5, approaching overbought territory but still below the 70 threshold, while the MACD line (0.48) remains above its signal (0.31), reinforcing short‑term upside momentum. The stock’s PE ratio of 11.97 is well below the industry average of 16.69, and the DCF‑derived fair value suggests roughly a 9% upside, signaling undervaluation. With a dividend yield of 3.08% and a modest payout ratio of 35%, the dividend appears sustainable and attractive for income‑focused investors.
Fundamentally, HMN posted $1.71 B in revenue with 3.1% growth and a solid 38.8% gross margin, while operating and net margins of 13.9% and 9.6% reflect healthy profitability. EPS is accelerating, with forward EPS projected at $5.06 versus trailing $3.98, and free cash flow of $275 M supports ongoing operations and dividend payments. The balance sheet shows moderate leverage (debt‑to‑equity ~40%) and low beta (0.22), indicating limited market volatility; 30‑day price volatility is 17.5%, and volume remains stable. Recent earnings calls highlighted a 20% YoY rise in core EPS and a 6% increase in insurance and fee revenue, offset by a slight revenue miss versus estimates, underscoring resilient earnings growth amid modest top‑line pressure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical bullishness with price above key SMAs
  • Strong dividend yield and sustainable payout
  • Momentum from recent EPS beat

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics relative to peers
  • Steady earnings growth and free cash flow generation
  • Low beta and moderate volatility supporting stable returns

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Attractive dividend yield with long‑term sustainability
  • Consistent profitability and modest revenue growth
  • Favorable risk profile due to low leverage and US‑centric operations

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin9.63%
P/E Ratio12.0
ROE11.74%
ROA1.03%
Debt/Equity40.40
P/B Ratio1.3
Op. Cash Flow$473.7M
Free Cash Flow$275.6M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI69.5
Support$43.65
Resistance$47.72
MA 20$45.53
MA 50$44.34
MA 200$44.67
MACDBullish
VolumeStable
Fear & Greed Index91.5

Valuation

Fair Value$89.21
Target Price$52.00
Upside/Downside9.13%
GradeUndervalued
TypeBlend
Dividend Yield3.08%

Risk Assessment

Beta0.22
Volatility17.55%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.